Therapy News and Research

RSS

Benefits of convalescent plasma for COVID-19 patients still remain unclear

With vaccines and therapeutic drugs for COVID-19 still under development, doctors are wondering whether antibody-rich plasma infusions from the blood of recovered patients could be a more immediate way to keep hospitalized patients alive and off ventilators.

17 Jun 2020

Oral antibiotic therapy can effectively treat infections in people who inject illicit drugs

People who inject illicit drugs can develop potentially deadly infections of the heart, blood, joints and soft tissues.

17 Jun 2020

Two clinical trials use low-dose X-rays to treat COVID-19 pneumonia

Previous studies have shown that low-dose, whole lung radiation in the form of X-rays can effectively treat severe pneumonia, with minimal side effects.

17 Jun 2020

New nanoparticle drug combination can help treat atherosclerosis

Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.

17 Jun 2020

Nanosponges could attack and neutralize SARS-COV-2 virus

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.

17 Jun 2020

Early intensive treatment of rheumatoid arthritis offers an opportunity to manage fatigue

Disease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases.

17 Jun 2020

Abbott's FreeStyle Libre system significantly reduces HbA1c levels in patients with type 2 diabetes

Abbott announced new late-breaking data demonstrating use of its FreeStyle Libre system, the world's leading sensor-based glucose monitoring technology, is associated with significant reduction in hemoglobin A1c (HbA1c) levels for people living with type 2 diabetes on either long-acting insulin or non-insulin therapy.

17 Jun 2020

BIA Separations launches novel PrimaS ligand technology to facilitate development of advanced therapies

BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of its novel PrimaS ligand technology.

17 Jun 2020

Neuroscientist discovers neuronal pulses in the human brain that activate after an injury

A neuroscientist's neon pink arm cast led him and fellow researchers at Washington University School of Medicine in St. Louis to discover previously undetected neuronal pulses in the human brain that activate after an immobilizing illness or injury.

17 Jun 2020

Nano-bio hybrid systems could deliver tumor therapy

Announcing a new article publication for BIO Integration journal. In this mini-review article the authors Yuhao Chen, Meng Du, Jinsui Yu, Lang Rao, Xiaoyuan Chen, and Zhiyi Chen from The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China and the National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, USA consider nanobiohybrids in cancer therapy.

17 Jun 2020

Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients

A new study has shown that potent antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could help protect against COVID-19 infection. Preliminary results in animal studies have so far proven successful. The study titled, "Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model," was published in the latest issue of the journal Science.

17 Jun 2020

Antibiotic X-206 effective against SARS-CoV-2 in vitro

The current study published on the preprint server bioRxiv aims to understand how these compounds affect SARS-CoV-2 in vitro. The researchers from Aarhus University in Denmark examined 11 natural PEIs, with a single synthetic analog, screening them for inhibitory activity against the CPE of SARS-CoV-2 infecting cultured cells with overexpression of TMPRSS2, a serine protease that is instrumental in cleaving the spike protein of the virus.

16 Jun 2020

Anti-TNF drug preserves beta-cell function in newly diagnosed pediatric patients with Type 1 diabetes

In research led by a University at Buffalo pediatric endocrinologist, a drug called golimumab showed that it preserved beta-cell function in children and young adults with newly diagnosed Type 1 diabetes, according to findings from a Phase 2 study.

16 Jun 2020

Two potent small molecules appear to suppress tumor growth in multiple cancers

City of Hope scientists have identified and developed two potent small molecules that appear to suppress tumor growth in multiple cancers even when other treatments cease to work, possibly due to the development of drug resistance.

16 Jun 2020

Experts evaluate options for treating cognitive deficits in multiple sclerosis

Experts in cognitive research evaluated the status of available treatments as well as promising strategies for treating cognitive deficits in multiple sclerosis.

16 Jun 2020

Researchers develop a simple tool for making mouse models of COVID-19

Until there are effective treatments or vaccines, the COVID-19 pandemic will remain a significant threat to public health and economies around the world. A major hurdle to developing and testing new anti-viral therapies and vaccines for COVID-19 is the lack of good, widely available animal models of the disease.

16 Jun 2020

Research team generates comprehensive developmental map of human T-cells

Chintan Parekh, MD, of The Saban Research Institute of Children's Hospital Los Angeles, has led a team of investigators that generated a comprehensive roadmap for how T-cells develop in the human thymus.

16 Jun 2020

Antibody cocktail with potential to treat COVID-19 identified

Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

16 Jun 2020

Exercise has profound protective effect in mouse models of Friedreich's ataxia

A top exercise researcher at the University of Virginia School of Medicine is urging clinical trials of exercise in patients with Friedreich's ataxia after finding that physical activity has a "profound" protective effect in mouse models of the debilitating genetic disease.

16 Jun 2020

UCLA receives nearly $14 million NIH grant to investigate immunotherapy to destroy HIV

UCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.

16 Jun 2020

Therapy News and Research

Benefits of convalescent plasma for COVID-19 patients still remain unclear

Oral antibiotic therapy can effectively treat infections in people who inject illicit drugs

Two clinical trials use low-dose X-rays to treat COVID-19 pneumonia

New nanoparticle drug combination can help treat atherosclerosis

Nanosponges could attack and neutralize SARS-COV-2 virus

Early intensive treatment of rheumatoid arthritis offers an opportunity to manage fatigue

Abbott's FreeStyle Libre system significantly reduces HbA1c levels in patients with type 2 diabetes

BIA Separations launches novel PrimaS ligand technology to facilitate development of advanced therapies

Neuroscientist discovers neuronal pulses in the human brain that activate after an injury

Nano-bio hybrid systems could deliver tumor therapy

Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients

Antibiotic X-206 effective against SARS-CoV-2 in vitro

Anti-TNF drug preserves beta-cell function in newly diagnosed pediatric patients with Type 1 diabetes

Two potent small molecules appear to suppress tumor growth in multiple cancers

Experts evaluate options for treating cognitive deficits in multiple sclerosis

Researchers develop a simple tool for making mouse models of COVID-19

Research team generates comprehensive developmental map of human T-cells

Antibody cocktail with potential to treat COVID-19 identified

Exercise has profound protective effect in mouse models of Friedreich's ataxia

UCLA receives nearly $14 million NIH grant to investigate immunotherapy to destroy HIV

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News